Clinically Documented Ingredients Offer Proven Digestive Benefits
DuPont Nutrition & Health will present its clinically documented probiotics and lactitol at this year’s CPhI Worldwide. The company’s DuPont Danisco range of premium probiotics and lactitol have been shown to have beneficial effects for digestive health in multiple human clinical studies.
Studies show that HOWARU Restore premium probiotics can help relieve gut stress caused by antibiotic treatment. In a recent clinical study with more than 500 people undergoing antibiotic therapy, results included a significant reduction of the number of episodes of antibiotic-associated diarrhoea. In addition, subjects experienced a significant reduction in diarrhoea-associated symptoms, such as fever, bloating and abdominal pain.
Clinical studies have demonstrated the gentle constipation relief provided by OsmoAid lactitol. In both children and adult populations, OsmoAid has been shown to be a well-tolerated laxative with none of the harsh side effects of other anti-constipation ingredients.
Now more than ever, DuPont demonstrates its capabilities in the area of market-ready concepts. With its own blending and packaging facilities — along with a network of carefully selected contract manufacturer partners — DuPont meets the needs of the pharmaceutical and dietary supplement industries.
Going well beyond digestive health, the combined DuPont Nutrition & Health portfolio addresses consumer needs within immune health, oral health, bone health, cardiovascular health, weight management, children’s nutrition, sports nutrition and healthy ageing.
Stand 63A04
DuPont Nutrition & Health, +1 608 395 2662, kelly.czerwonka@dupont.com,